Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
|---|---|---|---|
| Total revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expense | -82.10%1.2M | 560.58%6.7M | 1.01M |
| Selling and administrative expenses | 24.46%677.56K | 25.39%544.4K | --434.15K |
| -General and administrative expense | 24.46%677.56K | 25.39%544.4K | --434.15K |
| Depreciation amortization depletion | 19.25%24.52K | 1,001.77%20.56K | --1.87K |
| -Depreciation and amortization | 19.25%24.52K | 1,001.77%20.56K | --1.87K |
| Other operating expenses | -91.90%497.28K | 960.78%6.14M | --578.52K |
| Operating profit | 82.10%-1.2M | -560.58%-6.7M | -1.01M |
| Net non-operating interest income (expenses) | -33.76%77.07K | 87.15%116.35K | 62.17K |
| Non-operating interest income | -33.76%77.07K | 87.15%116.35K | --62.17K |
| Other net income (expenses) | -99.99%41 | 1,461.75%468.03K | 29.97K |
| Other non-operating income (expenses) | -99.99%41 | 1,461.75%468.03K | --29.97K |
| Income before tax | 81.66%-1.12M | -563.21%-6.12M | -922.4K |
| Income tax | 0 | 0 | 0 |
| Earnings from equity interest net of tax | |||
| Net income | 81.66%-1.12M | -563.21%-6.12M | -922.4K |
| Net income continuous operations | 81.66%-1.12M | -563.21%-6.12M | ---922.4K |
| Noncontrolling interests | |||
| Net income attributable to the company | 81.66%-1.12M | -563.21%-6.12M | -922.4K |
| Preferred stock dividends | |||
| Other under preferred stock dividend | |||
| Net income attributable to common stockholders | 81.66%-1.12M | -563.21%-6.12M | -922.4K |
| Diluted earnings per share | 84.68%-0.0148 | -287.95%-0.0966 | -0.0249 |
| Basic earnings per share | 84.68%-0.0148 | -287.95%-0.0966 | -0.0249 |
| Dividend per share | |||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |